Regeneron drops RSV therapy on trial failure
admin 15th August 2017 Uncategorised 0Regeneron Pharmaceuticals is pulling the plug on an experimental therapy in development for preventing respiratory syncytial virus (RSV) infection in infants, after a disappointing performance in a late-stage trial.
More: Regeneron drops RSV therapy on trial failure
Source: News